Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Numinus Wellness Inc (NUMI.VN)

Numinus Wellness Inc (NUMI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies

Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary  – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing...

NUMIF : 0.0365 (+4.89%)
NUMI.VN : 0.580 (+9.43%)
CYBN.NE : 8.2500 (-0.84%)
NVMDF : 0.2700 (+35.00%)
NM.CN : 0.295 (unch)
MYCOF : 0.0037 (+37.04%)
MYCO : 24.73 (-0.20%)
CYBN : 5.93 (-0.17%)
MYCO.NE : 0.1400 (+3.70%)
MCUR.CN : 0.075 (+36.36%)
MCURF : 0.5070 (+1,391.18%)
Potential $3 Trillion Healthcare Tech Transformation Underway

“Medical treatment has made astonishing advances over the years. But the packaging and delivery of that treatment are often inefficient, ineffective, and consumer unfriendly.” That’s what Harvard...

NUMIF : 0.0365 (+4.89%)
CMPS : 5.20 (-1.61%)
NUMI.VN : 0.580 (+9.43%)
ATAI : 4.00 (-3.15%)
MNMD : 11.35 (-2.41%)
MCUR.CN : 0.075 (+36.36%)
MCURF : 0.5070 (+1,391.18%)

Barchart Exclusives

3 High-Growth Dividend Kings For Generations of Income - And Still Rated “Buy”
Dividend Kings with 20%+ YTD gains and strong analyst ratings show rare momentum, reliable income, and long-term stability across multiple sectors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar